294 related articles for article (PubMed ID: 34679437)
1. Dysregulation of miRNAs in DLBCL: Causative Factor for Pathogenesis, Diagnosis and Prognosis.
Alsaadi M; Khan MY; Dalhat MH; Bahashwan S; Khan MU; Albar A; Almehdar H; Qadri I
Diagnostics (Basel); 2021 Sep; 11(10):. PubMed ID: 34679437
[TBL] [Abstract][Full Text] [Related]
2. miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
Troppan K; Wenzl K; Pichler M; Pursche B; Schwarzenbacher D; Feichtinger J; Thallinger GG; Beham-Schmid C; Neumeister P; Deutsch A
Int J Mol Sci; 2015 Aug; 16(8):18077-95. PubMed ID: 26251897
[TBL] [Abstract][Full Text] [Related]
3. Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
Marchesi F; Regazzo G; Palombi F; Terrenato I; Sacconi A; Spagnuolo M; Donzelli S; Marino M; Ercolani C; Di Benedetto A; Blandino G; Ciliberto G; Mengarelli A; Rizzo MG
J Exp Clin Cancer Res; 2018 May; 37(1):95. PubMed ID: 29716630
[TBL] [Abstract][Full Text] [Related]
4. Profiling of microRNAs by next-generation sequencing: Potential biomarkers for diffuse large B-cell lymphoma.
Bahashwan S; Alsaadi M; Barefah A; Almahdi H; Alahwal H; Almohammadi A; Radhwi O; Daous Y; Idrees S; Almehdar H; Qadri I
J Taibah Univ Med Sci; 2024 Jun; 19(3):619-627. PubMed ID: 38812724
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of microRNAs from the miR-17-92 paralog clusters in AIDS-related non-Hodgkin's lymphomas.
Thapa DR; Li X; Jamieson BD; Martínez-Maza O
PLoS One; 2011; 6(6):e20781. PubMed ID: 21698185
[TBL] [Abstract][Full Text] [Related]
6. Screening and identification of differentially expressed microRNAs in diffuse large B-cell lymphoma based on microRNA microarray.
Gao HX; Li SJ; Wang MB; Yan SF; Cui WL; Ma ZP; Xue J; Sang W; Zhang W; Li XX
Oncol Lett; 2021 Nov; 22(5):753. PubMed ID: 34539857
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients.
Lim EL; Trinh DL; Scott DW; Chu A; Krzywinski M; Zhao Y; Robertson AG; Mungall AJ; Schein J; Boyle M; Mottok A; Ennishi D; Johnson NA; Steidl C; Connors JM; Morin RD; Gascoyne RD; Marra MA
Genome Biol; 2015 Jan; 16(1):18. PubMed ID: 25723320
[TBL] [Abstract][Full Text] [Related]
9. Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL).
Mazan-Mamczarz K; Gartenhaus RB
Leuk Res; 2013 Nov; 37(11):1420-8. PubMed ID: 24054860
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
11. Systematic Review of the Potential of MicroRNAs in Diffuse Large B Cell Lymphoma.
Larrabeiti-Etxebarria A; Lopez-Santillan M; Santos-Zorrozua B; Lopez-Lopez E; Garcia-Orad A
Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30691158
[TBL] [Abstract][Full Text] [Related]
12. mRNA expression profile analysis reveals a C-MYC/miR-34a pathway involved in the apoptosis of diffuse large B-cell lymphoma cells induced by Yiqichutan treatment.
Zhai L; Zhao Y; Liu Z; Wu J; Lin L
Exp Ther Med; 2020 Sep; 20(3):2157-2165. PubMed ID: 32765691
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in B-cell lymphomas: how a complex biology gets more complex.
Musilova K; Mraz M
Leukemia; 2015 May; 29(5):1004-17. PubMed ID: 25541152
[TBL] [Abstract][Full Text] [Related]
14. Identification of Circulating Serum Multi-MicroRNA Signatures in Human DLBCL Models.
Beheshti A; Stevenson K; Vanderburg C; Ravi D; McDonald JT; Christie AL; Shigemori K; Jester H; Weinstock DM; Evens AM
Sci Rep; 2019 Nov; 9(1):17161. PubMed ID: 31748664
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA Biomarkers in Canine Diffuse Large B-Cell Lymphoma.
Elshafie NO; Nascimento NCD; Lichti NI; Kasinski AL; Childress MO; Santos APD
Vet Pathol; 2021 Jan; 58(1):34-41. PubMed ID: 33287683
[TBL] [Abstract][Full Text] [Related]
16. Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: a systematic review.
Lopez-Santillan M; Larrabeiti-Etxebarria A; Arzuaga-Mendez J; Lopez-Lopez E; Garcia-Orad A
Oncotarget; 2018 Apr; 9(32):22850-22861. PubMed ID: 29854319
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNA-125b and microRNA-130a expression profiles predict chemoresistance to R-CHOP in diffuse large B-cell lymphoma patients.
Yuan WX; Gui YX; Na WN; Chao J; Yang X
Oncol Lett; 2016 Jan; 11(1):423-432. PubMed ID: 26870228
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index.
Due H; Brøndum RF; Young KH; Bøgsted M; Dybkær K
BMC Cancer; 2020 Mar; 20(1):237. PubMed ID: 32192453
[TBL] [Abstract][Full Text] [Related]
19. Peripheral Blood Cells from Patients with Hodgkin's and Diffuse Large B Cell Lymphomas May Be a Better Source of Candidate Diagnostic miRNAs Than Circulating miRNAs.
Paszkiewicz-Kozik E; Paziewska A; Kulecka M; Dąbrowska M; Kluska A; Bałabas A; Piątkowska M; Ambrożkiewicz F; Tajer J; Osiadacz W; Romejko-Jarosińska J; Kotarska M; Żeber-Lubecka N; Karczmarski J; Popławska L; Mikula M; Rutkowski P; Walewski J; Ostrowski J
Biomed Res Int; 2021; 2021():3212878. PubMed ID: 33628777
[TBL] [Abstract][Full Text] [Related]
20. High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma.
Marques SC; Ranjbar B; Laursen MB; Falgreen S; Bilgrau AE; Bødker JS; Jørgensen LK; Primo MN; Schmitz A; Ettrup MS; Johnsen HE; Bøgsted M; Mikkelsen JG; Dybkær K
Exp Hematol; 2016 Apr; 44(4):238-46.e2. PubMed ID: 26854484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
